Latest posts
-
CBD and PTSD Research: Clinical Trials, VA Studies and Evidence Gaps
By TakeHempGummies.com Consumer Research Desk Right now, there is not enough research to say that CBD treats PTSD. The National Center for PTSD, part of the U.S. Department of Veterans Affairs, states that research to date has produced insufficient evidence to support cannabis as a PTSD treatment, and some studies suggest chronic cannabis use can…
-
Hemp Product Batch Consistency: Why the Same Brand Can Test Differently
By TakeHempGummies.com Consumer Research Desk Why Two Bottles From the Same Hemp Brand Can Test Differently Hemp gummies from the same brand can vary from batch to batch because the raw hemp plant, the extraction process, and the manufacturer’s quality control all vary slightly with each production run. A Certificate of Analysis (COA) only tells…
-
Hemp Gummies and Digestive Symptoms: IBS Marketing vs Available Research
By TakeHempGummies.com Consumer Research Desk Do Hemp Gummies Actually Help IBS and Digestive Symptoms? No hemp or CBD gummy is approved to treat irritable bowel syndrome (IBS) or any other digestive condition. Marketing language that suggests otherwise is running ahead of the science. Federal health agencies say research on cannabinoids and the gut is still…
-
Raw Cannabinoids: What CBDa and THCa Are and Why They Need Different Evaluation
By TakeHempGummies.com Consumer Research Desk What Are CBDa and THCa? CBDa (cannabidiolic acid) and THCa (tetrahydrocannabinolic acid) are the raw, acidic forms of CBD and THC that exist naturally in the fresh, unheated cannabis or hemp plant. The plant does not produce CBD or THC directly. It produces these acidic precursors first, and heat converts…
-
CBD and Inflammatory Conditions: Arthritis Claims and Evidence Boundaries
By TakeHempGummies.com Consumer Research Desk Does CBD Help With Arthritis and Joint Inflammation? Right now, the honest answer is: nobody knows for sure. Most research on CBD and inflammation comes from animal studies and small, short human trials — not the kind of large, long-term studies needed to prove a product works for arthritis. The…
-
Hemp Gummies and Seizure Context: Epidiolex vs OTC CBD Products
By TakeHempGummies.com Consumer Research Desk Epidiolex vs. Hemp Gummies: What’s the Real Difference for Seizures? Epidiolex is the only cannabidiol (CBD) product the FDA has approved as a medicine, and it’s approved specifically to treat seizures linked to three rare epilepsy conditions. Hemp gummies sold online or in stores are not approved to treat, prevent,…
-
CBG (Cannabigerol): The Emerging Cannabinoid and Its Early Research Profile
By TakeHempGummies.com Consumer Research Desk What Is CBG and What Does the Research Actually Show? Cannabigerol, or CBG, is one of more than 100 cannabinoids found in the cannabis plant. It does not cause a high. Right now, human research on CBG by itself is very limited, and no CBG product has FDA approval for…
-
CBD and Migraines: What Headache Research Shows and What Remains Unknown
By TakeHempGummies.com Consumer Research Desk Does CBD Help Migraines? Here’s What the Evidence Actually Shows Right now, there is no CBD-specific clinical trial proving that CBD reduces migraine attacks. Most human cannabinoid research on pain conditions has studied products containing THC, cannabis’s psychoactive compound, or a combination of THC and CBD, rather than CBD by…
-
International Hemp Product Regulations: How Standards Differ From US Rules
By TakeHempGummies.com Consumer Research Desk How Hemp Rules Differ Around the World The United States defines legal hemp as cannabis with no more than 0.3% THC, but other countries use different limits and different rules for what counts as a legal hemp product. The European Union, United Kingdom, Canada, and Australia each treat hemp gummies,…
-
Hemp Gummies and Focus: ADHD Marketing vs Available Evidence
By TakeHempGummies.com Consumer Research Desk Do Hemp Gummies Help With Focus or ADHD? No major federal health agency has found that hemp gummies improve focus or treat ADHD symptoms. The National Institutes of Health’s own summary of cannabis and cannabinoid research does not list attention, focus, or ADHD among the conditions it has studied at…